DashboardPortfoliosWatchlistCommunityDiscoverScreener
  • Community
  • /
  • United States
  • /
  • Healthcare
Author Program NEWCreate Narrative
DRIO logo

DarioHealth Corp. Stock Price

NasdaqCM:DRIO Community·US$64.5m Market Cap
  • 3 Narratives written by author
  • 0 Comments on narratives written by author
  • 4 Fair Values set on narratives written by author
Author Program NEWCreate Narrative

DRIO Share Price Performance

US$6.93
-0.18 (-2.53%)
​
US$15.25
Fair Value
US$6.93
-0.18 (-2.53%)
54.6% undervalued intrinsic discount
US$15.25
Fair Value
Price US$6.93
AnalystConsensusTarget US$15.25
AnalystHighTarget US$28.00
AnalystLowTarget US$8.00
Tue, 28 Jul 26
Fair ValueUS$15.25
Share Pricen/a

DRIO Community Narratives

AN
AnalystConsensusTarget
AnalystConsensusTarget's
Fair Value
·
Fair Value US$15.25 54.6% undervalued intrinsic discount

DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential

0users have liked this narrative
0users have commented on this narrative
4users have followed this narrative
AN
AnalystHighTarget
AnalystHighTarget's
Fair Value
·
Fair Value US$28 75.3% undervalued intrinsic discount

Aging Demographics And Telehealth Will Transform Chronic Care

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
AN
AnalystLowTarget
AnalystLowTarget's
Fair Value
·
Fair Value US$8 13.4% undervalued intrinsic discount

Digital Health Onboarding Delays And Rising Costs Will Ease Eventually

0users have liked this narrative
0users have commented on this narrative
0users have followed this narrative
DRIO logo
DarioHealth
13.4% undervalued intrinsic discount

Digital Health Onboarding Delays And Rising Costs Will Ease Eventually

View narrative
AN
AnalystLowTarget
AnalystLowTarget
Updated 13 Aug
Read Narrative
DRIO logo
DarioHealth
54.6% undervalued intrinsic discount

DRIO: New Client Wins And Pricing Initiatives Will Drive Upside Potential

View narrative
AN
AnalystConsensusTarget
AnalystConsensusTarget
Updated 28 Jul
Read Narrative
DRIO logo
DarioHealth
75.3% undervalued intrinsic discount

Aging Demographics And Telehealth Will Transform Chronic Care

View narrative
AN
AnalystHighTarget
AnalystHighTarget
Updated 26 Jun
Read Narrative

Trending Discussion

No trending discussion available.

Recently Updated Narratives

AN
AnalystLowTarget
DRIO logo

DRIO: GLP 1 Expansion And Margin Gains Will Shape Balanced Outlook

Fair Value: US$8 13.4% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystConsensusTarget
DRIO logo

DRIO: AI Platform And 2026 Contracts Will Support Recovery

Fair Value: US$15.25 54.6% undervalued intrinsic discount
4 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative
AN
AnalystHighTarget
DRIO logo

DRIO: Clinical Outcomes And Expanded Partnerships Will Drive Future Share Rebound

Fair Value: US$28 75.3% undervalued intrinsic discount
0 fair values setusers have set this as their fair value
0 commentsusers have commented on this narrative
0 likesusers have liked this narrative

Snowflake Analysis

Fair value with mediocre balance sheet.

3 Risks
3 Rewards
View Full Analysis

DarioHealth Corp. Key Details

US$21.0m

Revenue

US$8.1m

Cost of Revenue

US$12.9m

Gross Profit

US$19.9m

Other Expenses

-US$7.0m

Earnings

Last Reported Earnings
Jun 30, 2026
Next Reporting Earnings
n/a
-0.71
61.57%
-33.33%
56.4%
View Full Analysis

About DRIO

Founded
2011
Employees
163
CEO
Erez Raphael
WebsiteView website
www.dariohealth.com

DarioHealth Corp. operates as a digital health company in the United States and internationally. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health. The company offers Dario Connect, a solution used to create communities around specific health conditions to increase awareness and education; Dario Mind, a behavioral health offering that decreases the symptoms of stress, anxiety, and depression; Dario Move, focuses on improving posture to alleviate pain with medical device; and Dario Health, a self-care application and virtual coaching platform for diabetes, hypertension, and weight management and GLP-1. It also provides bundled full-suite or partial-suite subscriptions. The company was formerly known as LabStyle Innovations Corp. and changed its name to DarioHealth Corp. in July 2016. DarioHealth Corp. was incorporated in 2011 and is based in New York, New York.

Recent DRIO News & Updates

Analysis Article • Aug 17

Some Analysts Just Cut Their DarioHealth Corp. (NASDAQ:DRIO) Estimates

The latest analyst coverage could presage a bad day for DarioHealth Corp. ( NASDAQ:DRIO ), with the analysts making...

Recent updates

No updates

DarioHealth Corp. Competitors

ZJYL logo

Jin Medical International

Symbol: NasdaqCM:ZJYL
Market cap: US$161.2m
DH logo

Definitive Healthcare

Symbol: NasdaqGS:DH
Market cap: US$149.2m
LUCD logo

Lucid Diagnostics

Symbol: NasdaqCM:LUCD
Market cap: US$149.2m
LFMD logo

LifeMD

Symbol: NasdaqGM:LFMD
Market cap: US$146.0m
View more competitors

Make Better Investing Decisions Anywhere

Scan to download
Open AppStoreOpen Google Play
Chrome Web Store
Level 5, 320 Pitt Street, Sydney
Financial Data provided by S&P Global Market Intelligence LLC, analysis provided by Simply Wall Street Pty Ltd. Copyright © 2026, S&P Global Market Intelligence LLC. All rights reserved.
View Data Sources
Markets
  • US: NYSE & NASDAQ
  • UK: FTSE
  • Australia: ASX
  • India: NIFTY
  • Canada: TSX
  • South Africa: JSE
  • Japan: NIKKEI
  • South Korea: KOSPI
  • Germany: DAX
Investing Ideas
  • Undervalued Companies
  • Dividend Powerhouses
  • Insider Buying
  • Nuclear Energy
  • Autonomous Vehicles
  • Artificial Intelligence
  • Crypto and Blockchain
  • Cybersecurity
  • More ideas
Stock Communities
  • AstraZeneca
  • HSBC Holdings
  • Shell
  • Unilever
  • Diageo
  • Rio Tinto Group
  • RELX
  • BP
  • Barclays
Features & Tools
  • Portfolio Tracker
  • Stock Screener & Alerts
  • Narratives & Fair Values
  • Dividend Calculator
News & Discovery
  • Latest Stock News
  • Global Market Insights
  • The Foxhole
  • Investing Ideas
  • Community Narratives
  • What's New
Simply Wall St
  • Plans & Pricing
  • Advertising
  • About Us
  • Contact Us
  • Careers
  • Help Center
  • Learn Stock Investing
  • Affiliate Program
  • Business & Enterprise
  • Charlie AI
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.
© 2026 Simply Wall Street Pty Ltd, US Design Patent #29/544/281, Community and European Design Registration #2845206
  • Terms and Conditions
  • Privacy Policy
  • AI Terms
  • Financial Services Guide